Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Drug Design, Development and Therapy|July 27, 2017
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohortSebastian Bernuth, Daniel Grimm, Johanna Vollmar, et al.
Journal of Clinical Medicine|October 14, 2022
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre StudyLea Penzkofer, Jens Mittler, Stefan Heinrich, et al.
BMC Cancer|July 11, 2019
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette studyStefan Heinrich, Marc Besselink, Markus Moehler, et al.
Cancers|July 27, 2022
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under ImmunotherapyLukas Müller, Simon Johannes Gairing, Roman Kloeckner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2023
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimatesLukas Müller, Simon J Gairing, Friedrich Foerster, et al.
Oncology Reports|February 6, 2019
Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolizationAnja Lautem, Frank Simon, Maria Hoppe-Lotichius, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Sebastian Huss, Helen Künstlinger, Eva Wardelmann, et al.
Trials|May 13, 2022
Patient-individualized resection planning in liver surgery using 3D print and virtual reality (i-LiVR)-a study protocol for a prospective randomized controlled trialTobias Huber, Laura Isabel Hanke, Christian Boedecker, et al.
Cancers|February 11, 2023
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single CenterLea Penzkofer, Lisa-Katharina Gröger, Maria Hoppe-Lotichius, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2025
Vascular resection and reconstruction in surgery for advanced intrahepatic cholangiocarcinoma - single center experience with 59 vascular resectionsHauke Lang, Lisa-Katharina Gröger, Beate K Straub, et al.
Pageof 8